Andy Chong is an accomplished automation engineer with close to 20 years of experience in biopharmaceutical industry. He is currently serving as the Director of Automation Engineering at Gilead Sciences, a leading research-based biopharmaceutical company.

In his role at Gilead Sciences, Andy leads a team responsible for overseeing and maintaining automation-based systems and solutions that provide a flexible, innovative, highly efficient, compliant, and quality-focused environment for research and development and manufacturing. He is instrumental in developing, planning, and implementing projects and solutions in collaboration with cross-functional teams, ensuring successful programs and customer satisfaction.

Andy has been a key driver in Gilead's Corporate Pharma 4.0 Digital Transformation initiative, leading the evaluation and introduction of new Pharma 4.0 tools. He also plays a pivotal role in developing automation technical standards and procedures to ensure the highest level of efficiency and quality within the organization.  Prior to his current role, Andy served as the Principal Automation Engineer at Gilead Sciences for a span of seven years. During this time, he was responsible for overseeing all capital automation projects in Gilead's Foster City location, including the design, installation, commissioning, and qualification of the Building Management System (BMS) and Process Control System (PCS).